Table 3. Chondroitin sulfate and heparan sulfate fraction in total sulfated glycosaminoglycan in urine of healthy controls, urolithiasis patients, children of control (CC) and children of urolithiasis (UC).
Control | Urolithiasis | CC | UC | |
---|---|---|---|---|
Chondroitin sulfate/Total sGAGs (%) | 61.7±21.4 | 56.6±24.5 | 53.5±23.4 | 56.9±18.2 |
Heparan sulfate/Total sGAGs (%) | 15.7±8.0 | 23.2±16.8* | 15.0±8.5 | 22.8±7.6# |
*p < 0.05 compared with Control
#p < 0.05 compared with CC